Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
P
211
Pain control associated with opioid and gabapentinoid prescription after elective knee replacement
Favorite
C20
Patient characteristics and treatment patterns for migraine patients initiating erenumab in Denmark and Sweden
Favorite
110
Patterns of Antibiotic Prescribing for Urinary Tract Infections and Pneumonia by Provider Specialty in Nursing Home Care
Favorite
111
Patterns of Antibiotic Utilization for Urinary Tract Infection During Pregnancy, 2007-2020
Favorite
153
Patterns Of Antidepressant Prescribing During Pregnancy Between 1996 And 2018 Using The Clinical Practice Research Datalink
Favorite
084
Patterns of antiseizure medications prescriptions among pregnant people with epilepsy: a utilization study in three Canadian provinces
Favorite
193
Patterns of Initiation and Discontinuation of Medications for Opioid Use Disorder in Commercially Insured Individuals in the US
Favorite
099
Patterns of prescription medication use during pregnancy in the United States, 1997–2018
Favorite
237
Paxlovid and COVID-19 related hospitalization or death in clinically extremely vulnerable patients
Favorite
C21
Paxlovid or Molnupiravir Post-Treatment Medication Use Evaluation of Rebound COVID-19
Favorite
141
Paxlovid Prophylaxis or Treatment in Pregnancy: Data from the Organization of Teratology Information Specialists (OTIS) Pregnancy Registry
Favorite
118
Pediatric and Adolescent Medication Use Before and During COVID-19: A Population-Based Cohort Study in Manitoba, Canada
Favorite
282
Pediatric observational effectiveness evaluation studies in the EU PAS Register: What can we learn from study characteristics?
Favorite
078
Perception of Facilitators and Barriers to Strengthen restriction of non-medical use opioid prescription among healthcare practitioner in China: a qualitative study
Favorite
252
Percutaneous Left Atrial Appendage Occlusion and Risk of Stroke, Hospitalized Bleeding and Death in Medicare Beneficiaries with Atrial Fibrillation
Favorite
245
Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications before and after the approval of Ablysinol
Favorite
040
Persistence Associated With The Use Of Biologicals For The Treatment Of Ankylosing Spondylitis In The Brazilian Public Health System
Favorite
185
Personalize My Treatment (PMT): The First Pan-Canadian Cancer Patient Databank Suitable for Generation of Oncology Real-World Insights
Favorite
212
Personalized Prescribing Portraits and Evidence Summaries on First-line Antihypertensive Prescribing: A Factorial Randomized Trial of Audit-and-Feedback
Favorite
076
Pharmacist knowledge, attitudes, practice and barriers towards providing health screening services in the community pharmacy
Favorite
033
Pharmacists’ Perspectives on Facilitators and Barriers to Pharmacist Prescribing for Patients admitted to Hospital within Nova Scotia Health
Favorite
C42
Pharmacogenetic Testing in Switzerland: a Descriptive Study Using Swiss Claims Data
Favorite
009
Pharmacovigilance of pharmaceutical products in colorectal cancer: a systematic review and metanalysis
Favorite
C05
Phased Target Trial Design and Meta-Analysis in a Head-to-Head Treatment Comparison
Favorite
095
Phosphodiesterase Type 5 Inhibitors and The risk of Alzheimer’s Disease in Men with Erectile Dysfunction: A cohort study
Favorite
B28
Physician Knowledge of Safe Use of Cyproterone Acetate Monotherapies and Meningioma
Favorite
036
Physician Perceptions of and Experiences with Risk Evaluation and Mitigation Strategies: Results from a National Survey
Favorite
112
Pilot Project to Deprescribe Sedative-Hypnotic Drugs to Reduce Risk of Falls in Hospital Patients in Nova Scotia, Canada
Favorite
095
Pilot Surveillance of Infant Lower Respiratory Tract Infections and Respiratory Syncytial Virus in the United States During the COVID Pandemic
Favorite
094
Plans Change: A Competing Risks Analysis of Time to Unplanned Stopping of Long-Term Outpatient Antibiotic Treatment, 2015-2022
Favorite
C22
Plaque Psoriasis in the Real-World Setting: Disease Activity and Initiation of Advanced Therapy
Favorite
049
Poisonings with Antidepressants in Relation to Prescriptions; Venlafaxine and Amitriptyline Stands Out
Favorite
237
Polypharmacy and Hyperpolypharmacy among Patients with Chronic Kidney Disease: Prevalence, Geographical Difference, and Associated Factors
Favorite
143
Polypharmacy's association to mortality: A methodological case study
Favorite
145
Ponesimod Pregnancy Outcomes Enhanced Monitoring (POEM) Program to Evaluate Reproductive and Embryofetal Toxicity
Favorite
A31
Population-Based Incidence of Influenza-Associated Serious Neuropsychiatric Events
Favorite
247
Post-authorisation safety study (PASS) assessing the risk of liver, renal, genitourinary, and diabetic ketoacidosis outcomes among users of empagliflozin versus DPP-4 inhibitors in patients with type 2 diabetes mellitus (T2D)
Favorite
263
Post-Authorization Safety Study: Cohort Event Monitoring for CYD-TDV Dengue Vaccine (DNG15)
Favorite
045
Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Favorite
275
Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine in China: a retrospective real-world study
Favorite
A52
Post-marketing surveillance of human papillomavirus (HPV)-related high-grade cervical disease in a cohort of Chinese women who received the 9-valent HPV vaccine
Favorite
112
Postpartum depressive symptoms among Danish new mothers and fathers before and during the COVID-19 pandemic
Favorite
C49
Potential inappropriate medication use among older patients with Parkinson’s disease: A cross sectional analysis of a national health insurance database in China
Favorite
065
Potential Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions(DDIs) of QT Prolonging Drugs in a cohort of Psychiatry Patients
Favorite
013
Potential Risk Factors for Delirium during Inpatient Rehabilitation: A Matched Case-Control Study
Favorite
114
Potentially inappropriate medications among elderly patients in Chinese primary healthcare facilities: a nationwide survey, 2017-2019
Favorite
109
Potentially inappropriate prescribing and its association with adverse drug reaction-related hospital admissions
Favorite
204
Predicting Drug Consumption in Relation to Respiratory Diseases: An Analysis of the National Organisation for the Provision of Health Services ( EOPYY) Dataset in Greece
Favorite
B36
Predicting HER2 Status in Non-Small Cell Lung Cancer using Machine Learning Approach for Precision Cancer Pharmacoepidemiology in Large Databases
Favorite
B37
Predictive Biomarkers for PD-1/PD-L1 Checkpoint Inhibitor Response in NSCLC – an Analysis of Clinical Trial and Real-world Data
Favorite
041
Predictors of effectiveness of biologic Disease-Modifying Antirheumatic Drugs (bDMARD) in the treatment of psoriatic arthritis
Favorite
059
Predictors of nonadherence to antihypertensives among adult initiating cancer treatment
Favorite
134
Predictors of Opioid Use Before and After Orthopaedic Surgery in an Australian Setting: A Multicentre, Cross-Sectional, Observational Study
Favorite
123
Pregnancy and Fetal Outcomes Following Maternal Exposure to Glatiramer Acetate in 3 Trimesters of Pregnancy
Favorite
121
Pregnancy and Fetal Outcomes Following Paternal Exposure to Glatiramer Acetate
Favorite
126
Pregnancy during a pandemic: pregnancy occurrence and outcomes during the SARS-CoV-2 pandemic
Favorite
125
Pregnancy Rates in Patients with Immune-mediated Inflammatory Diseases
Favorite
260
Preliminary Findings from a Non-Interventional Post-Authorization Safety Study (PASS) for Active Safety Surveillance of Comirnaty Vaccine Recipients in the EU
Favorite
124
Prescribing Trends of SGLT2 Inhibitors Among Patients with Heart Failure in the U.S., 2013-2020
Favorite
089
Prescription analysis emphasizing on medication adherence of antibiotics for lower respiratory tract infection
Favorite
007
Prescription Ranitidine Use and Population Exposure in Six Canadian Provinces, 1996 to 2019
Favorite
033
Prescription Sequence Symmetry Analysis of Administrative Claims Data for Detection of Opioid Use Adverse Events
Favorite
243
Prescription trends of PCSK9 inhibitors in Hong Kong
Favorite
157
Prevalence and characteristics of patients with advanced/metastatic NSCLC with HER2 mutations
Favorite
170
Prevalence and Incidence of Multiple System Atrophy in Real World Setting: Results from US Claims Database
Favorite
254
Prevalence and prognosis of hypoxia-inducible factor-2α (HIF-2α) pathway gene mutations across tumor types
Favorite
159
Prevalence and use of medications for autoimmune diseases during pregnancy
Favorite
218
Prevalence of Comorbidities and Multimorbidity Among Patients with Atherosclerotic Cardiovascular Disease: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
Favorite
146
Prevalence of multiple sclerosis in women of childbearing age potential in Europe: A contribution from IMI ConCEPTION
Favorite
206
Prevalence of Polypharmacy and Hyperpolypharmacy in Patients with Intellectual Disabilities: A Meta-Analysis
Favorite
187
Prevalence of rare blood cancers in Europe: a population-based network cohort study part of DARWIN EU®
Favorite
175
Prevalence of Risk Categories of Chronic Kidney Disease with and without Type 2 Diabetes
Favorite
174
Prevalence of syphilis risk factors in Colorado from 2010-2020
Favorite
B52
Preventing Heart Failure Admissions with Sodium-Glucose Cotransporter-2 Inhibitors versus Angiotensin Receptor-Neprilysin Inhibitors: A Target Trial Emulation Study
Favorite
018
Primary Care Prescribing of Cardiovascular System Medications (England, 2015-2019): Variation and Associations
Favorite
151
PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern
Favorite
A46
Progression to ESRD Among White, Black and Hispanic Diabetic Kidney Disease Patients: Real-World Evidence from Multiple Linked Claims Databases
Favorite
234
Protective effects of medications on cardiovascular events in systemic lupus erythematosus in real-life: a systematic new-user cohort study
Favorite
053
Proton pump inhibitors and risk of kidney diseases: An overview of meta-analyses
Favorite
061
Psychiatric Prescription Drug Utilization and Related Overdoses Among Commercially Insured Individuals in the United States, 2020
Favorite
055
Psychological and Neurological Adverse Drug Events Associated with Direct Acting Antivirals Agents Used for Hepatitis C Virus: Analysis and Comparison of the FDA Adverse Event Reporting System (FAERS) and Lexicomp
Favorite
015
Publicly funded access to prescription medicines in Brazil from 1998 to 2019
Favorite
027
Publicly funded prescription drugs dispensed to community dwelling New Brunswick older adults following hospital discharge for myocardial infarction between 2009 and 2017
Favorite
037
Purchases of Biological Medicines by the Ministry of Health During the Approval of Biosimilars in Brazil
Favorite
073
Purine antimetabolites associated pneumocystis jiroveci pneumonia among autoimmune and cancer population
Favorite
